Cardiometabolic Risks in Patients with Thyroid Cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Thyroid cancer is the most prevalent malignancy in South Korea, with a 5-year survival rate exceeding 100%. As the number of long-term survivors increases, non-cancer-related complications, particularly cardiovascular and metabolic diseases, have emerged as significant contributors to morbidity and mortality. This review aims to summarize current evidence on the association between thyroid cancer and cardiometabolic risk and highlight clinical implications for optimal management.
Abstract
Thyroid cancer is the most prevalent malignancy in South Korea, with a 5-year survival rate exceeding 100%. As the number of long-term survivors increases, non-cancer-related complications, particularly cardiovascular and metabolic diseases, have emerged as significant contributors to morbidity and mortality. This review aims to summarize current evidence on the association between thyroid cancer and cardiometabolic risk and highlight clinical implications for optimal management.